Therapeutic Fasting as a Novel Approach to Mitigate Musculoskeletal Symptoms in Breast Cancer Patients undergoing Aromatase Inhibitor Therapy: A Feasibility Study Protocol.

Meyer H, Koppold DA, Shaker O, Eden L, Schiffmann L, Konigorski S, Cramer H, Choi KA, Einsele H, Winkler M, Löffler C

Open source

DOI
10.1177/15347354261426272
Published
2026 Jan-Dec
Container
Integrative cancer therapies
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/15347354261426272,
  title = {Therapeutic Fasting as a Novel Approach to Mitigate Musculoskeletal Symptoms in Breast Cancer Patients undergoing Aromatase Inhibitor Therapy: A Feasibility Study Protocol.},
  author = {Meyer H and Koppold DA and Shaker O and Eden L and Schiffmann L and Konigorski S and Cramer H and Choi KA and Einsele H and Winkler M and Löffler C},
  year = {2026},
  journal = {Integrative cancer therapies},
  doi = {10.1177/15347354261426272},
  url = {https://doi.org/10.1177/15347354261426272}
}

RIS

TY  - JOUR
TI  - Therapeutic Fasting as a Novel Approach to Mitigate Musculoskeletal Symptoms in Breast Cancer Patients undergoing Aromatase Inhibitor Therapy: A Feasibility Study Protocol.
AU  - Meyer H
AU  - Koppold DA
AU  - Shaker O
AU  - Eden L
AU  - Schiffmann L
AU  - Konigorski S
AU  - Cramer H
AU  - Choi KA
AU  - Einsele H
AU  - Winkler M
AU  - Löffler C
PY  - 2026
JO  - Integrative cancer therapies
DO  - 10.1177/15347354261426272
UR  - https://doi.org/10.1177/15347354261426272
ER  - 

APA

H, M., DA, K., O, S., L, E., L, S., S, K., H, C., KA, C., H, E., M, W., & C, L. (2026). Therapeutic Fasting as a Novel Approach to Mitigate Musculoskeletal Symptoms in Breast Cancer Patients undergoing Aromatase Inhibitor Therapy: A Feasibility Study Protocol.. Integrative cancer therapies. https://doi.org/10.1177/15347354261426272

Source records